Mairs & Power Inc Edwards Lifesciences Corp Transaction History

Mairs & Power Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$81.41 - $94.33 $45,589 - $52,824	-560 Reduced 16.01%	2,938 $277,000
Q1 2023 May 15, 2023	BUY	$74.26 - $84.51 $259,761 - $295,615	3,498 New	3,498 $289,000
Q1 2022 May 16, 2022	SELL	$101.96 - $128.34 $162,422 - $204,445	-1,593 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $169,447 - $208,173	1,593 New	1,593 $206,000
Q2 2020 Aug 14, 2020	SELL	$57.54 - $76.95 $85,216 - $113,962	-1,481 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$71.7 - $82.09 $11,543 - $13,216	161 Added 12.2%	1,481 $346,000
Q3 2018 Nov 14, 2018	BUY	$45.7 - $58.03 $60,324 - $76,599	1,320 New	1,320 $230,000

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Mairs & Power Inc, based on Form 13F filings with the SEC.

Stay updated on Mairs & Power Inc with notifications on news.